Related Experiment Video
Updated: May 31, 2026

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
Published on: February 17, 2023
The effect Akt2 deletion on tumor development in Pten(+/-) mice
1Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois at Chicago, Chicago, IL 60607, USA.
Akt2 deficiency minimally impacts tumor development in Pten(+/-) mice, unlike Akt1. This suggests Akt1 plays a more critical role in inhibiting tumorigenesis across most tissues, with Akt2 showing specific effects in thyroid tumors.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- The serine/threonine kinase Akt is a key regulator of cell survival and proliferation, frequently hyperactivated in human cancers.
- Akt isoforms (Akt1, Akt2, Akt3) have distinct roles, but their specific contributions to tumorigenesis and the impact of their deficiencies remain incompletely understood.
- Previous studies demonstrated Akt1 deficiency significantly reduces tumor incidence in Pten(+/-) mice, inhibiting endometrial and prostate cancers.
Purpose of the Study:
- To investigate the specific role of Akt2 deficiency in tumorigenesis within the Pten(+/-) mouse model.
- To compare the effects of Akt1 versus Akt2 deficiency on tumor incidence across various tissues.
- To elucidate the mechanisms underlying the differential impact of Akt isoforms on cancer development.
Main Methods:
- Analysis of tumor incidence in Pten(+/-) mice with targeted Akt2 deficiency.
- Comparison of tumor development between Pten(+/-)Akt1(-/-) and Pten(+/-)Akt2(-/-) mouse models.
- Assessment of Akt isoform expression levels and blood insulin levels in the studied mouse models.
Main Results:
- Akt2 deficiency had minimal impact on prostate neoplasia, endometrial carcinoma, intestinal polyps, and adrenal lesions in Pten(+/-) mice.
- A significant decrease in thyroid tumor incidence was observed in Pten(+/-)Akt2(-/-) mice, correlating with high Akt2 expression in the thyroid.
- Unlike Akt1 deficiency, Akt2 deficiency did not markedly inhibit overall tumorigenesis in Pten(+/-) mice, potentially due to insufficient reduction in total Akt activity.
Conclusions:
- Akt1 plays a more critical role than Akt2 in suppressing tumorigenesis across most tissues in the Pten(+/-) model.
- Akt2 deficiency specifically inhibits thyroid tumor development in Pten(+/-) mice, highlighting tissue-specific isoform functions.
- Elevated insulin levels in Pten(+/-)Akt2(-/-) mice may compensate for Akt2 loss by increasing Akt1/Akt3 activity, thus limiting the therapeutic potential of targeting Akt2 alone.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...